Influence of nutritional deficiency on prognosis of renal cell carcinoma (RCC)

被引:39
|
作者
Ko, Kyungtae [1 ]
Park, Young H. [1 ]
Lee, Jeong W. [1 ]
Ku, Ja H. [1 ]
Kwak, Cheol [1 ]
Kim, Hyeon H. [1 ]
机构
[1] Seoul Natl Univ, Coll Med, Dept Urol, Seoul, South Korea
关键词
nutritional status; renal cell carcinoma; prognosis; body mass index; albumin; cholesterol; BODY-MASS INDEX; PRETREATMENT SERUM-ALBUMIN; FATTY-ACID SYNTHASE; INDEPENDENT PREDICTOR; COLORECTAL-CANCER; PANCREATIC-CANCER; KIDNEY CANCER; WEIGHT-LOSS; SURVIVAL; RISK;
D O I
10.1111/bju.12275
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective To evaluate the prognosis of patients with renal cell carcinoma (RCC) by nutritional status defined by body mass index (BMI), serum albumin and cholesterol. Patients and Methods This study retrospectively enrolled 1437 patients who underwent radical nephrectomy (932) or partial nephrectomy (505) for RCC. We assigned nutritional status according to the presence of none or one nutritional risk factor (control group) and two or all three of the following nutritional risk factors (nutritional deficiency group). The nutritional factors and thresholds were preoperative albumin level (< 3.5 g/dL), preoperative cholesterol level (< 220 mg/dL), and preoperative BMI (< 23 kg/m(2)) Results The patients' mean (sd) age was 55.23 (12.41) years and BMI was 24.36 (3.17) kg/m(2). The mean (sd) serum cholesterol level was 180.07 (38.24) mg/dL, and the albumin level was 4.2 (0.45) g/dL. In all, 141 (9.8%) patients had none of the nutritional deficiency criteria, 802 (55.8%) had one, 429 (29.9%) had two, and 65 (4.5%) had all three. Clinicopathological variables, i.e. female gender, high tumour stage, positive lymph node metastasis, positive distant metastasis, high nuclear grade and non-clear cell type histopathology were associated with the nutritional deficiency group. In multivariate Cox analysis, nutritional deficiency was an independent predictor for RCC recurrence (hazard ratio [HR] 1.39, 95% confidence interval [CI] 1.05-1.83, P = 0.020) and RCC-related mortality (HR 2.06, 95% CI 1.39-3.03, P < 0.001). Conclusion Nutritional deficiency defined by BMI, serum albumin and cholesterol is an important factor that predicts postoperative prognosis of patients with RCC who have undergone radical or partial nephrectomy.
引用
收藏
页码:775 / 780
页数:6
相关论文
共 50 条
  • [31] Prognostic significance of venous tumour thrombus consistency in patients with renal cell carcinoma (RCC)
    Weiss, Valerie L.
    Braun, Martin
    Perner, Sven
    Harz, Andreas
    Vorreuther, Roland
    Kristiansen, Glen
    Mueller, Stefan C.
    Ellinger, Joerg
    BJU INTERNATIONAL, 2014, 113 (02) : 209 - 217
  • [32] Urine Metabolomics for Renal Cell Carcinoma (RCC) Prediction: Tryptophan Metabolism as an Important Pathway in RCC
    Liu, Xiaoyan
    Zhang, Mingxin
    Liu, Xiang
    Sun, Haidan
    Guo, Zhengguang
    Tang, Xiaoyue
    Wang, Zhan
    Li, Jing
    Li, Hanzhong
    Sun, Wei
    Zhang, Yushi
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [33] Impact of body mass index in Korean patients with renal cell carcinoma
    Sung, Hyun Hwan
    Jeon, Seong Soo
    Park, Seo Yong
    Jeong, Byong Chang
    Seo, Seong Il
    Lee, Hyun Moo
    Choi, Han-Yong
    CANCER CAUSES & CONTROL, 2012, 23 (03) : 505 - 511
  • [34] Perioperative blood transfusion adversely affects prognosis after nephrectomy for renal cell carcinoma
    Abu-Ghanem, Yasmin
    Zilberman, Dorit E.
    Dotan, Zohar
    Kaver, Issac
    Ramon, Jacob
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (01) : 12.e15 - 12.e20
  • [35] Does Obesity Influence the Prognosis of Metastatic Renal Cell Carcinoma in Patients Treated with Vascular Endothelial Growth Factor-Targeted Therapy?
    Steffens, Sandra
    Gruenwald, Viktor
    Ringe, Kristina I.
    Seidel, Christoph
    Eggers, Hendrik
    Schrader, Mark
    Wacker, Frank
    Kuczyk, Markus A.
    Schrader, Andres J.
    ONCOLOGIST, 2011, 16 (11) : 1565 - 1571
  • [36] Influence of body mass index on prognosis of Japanese patients with renal cell carcinoma
    Awakura, Yasuo
    Nakamura, Eijiro
    Ito, Norlyuki
    Yamasaki, Toshinari
    Kamba, Tomomi
    Kamoto, Toshiyuki
    Ogawa, Osamu
    UROLOGY, 2007, 70 (01) : 50 - 54
  • [37] Prevalence, Treatment, and Prognosis of Tumor Thrombi in Renal Cell Carcinoma
    Kaptein, Fleur H. J.
    van der Hulle, Tom
    Braken, Sander J. E.
    Van Gennep, Erik J.
    Buijs, Jeroen T.
    Burgmans, Mark C.
    Cannegieter, Suzanne C.
    du Chatinier, Emma M. E.
    Huisman, Menno V.
    van Meerten, Els L. van Persijn
    Versteeg, Henri H.
    Pelger, Rob C. M.
    Klok, Frederikus A.
    JACC: CARDIOONCOLOGY, 2022, 4 (04): : 522 - 531
  • [38] Influence of Visceral Obesity on Oncologic Outcome in Patients with Renal Cell Carcinoma
    Naya, Yukio
    Zenbutsu, Satoki
    Araki, Kazuhiro
    Nakamura, Kazuyoshi
    Kobayashi, Masayuki
    Kamijima, Syuichi
    Imamoto, Takashi
    Nihei, Naoki
    Suzuki, Hiroyoshi
    IchikawaB, Tomohiko
    Igarashi, Tatsuo
    UROLOGIA INTERNATIONALIS, 2010, 85 (01) : 30 - 36
  • [39] Lipid metabolism reprogramming in renal cell carcinoma
    Heravi, Gioia
    Yazdanpanah, Omid
    Podgorski, Izabela
    Matherly, Larry H.
    Liu, Wanqing
    CANCER AND METASTASIS REVIEWS, 2022, 41 (01) : 17 - 31
  • [40] The Role of Obesity in Renal Cell Carcinoma Patients: Clinical-Pathological Implications
    Aurilio, Gaetano
    Piva, Francesco
    Santoni, Matteo
    Cimadamore, Alessia
    Sorgentoni, Giulia
    Lopez-Beltran, Antonio
    Cheng, Liang
    Battelli, Nicola
    Nole, Franco
    Montironi, Rodolfo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (22)